InfoBionic MoMe Receives 510k FDA Clearance
InfoBionic recently announced that is received 510(k) clearance by the FDA for its revolutionary wireless cardiac monitoring device called the MoMe Kardia. The Massachusetts based company is leveraging the versatility of the MoMe device as it is said to function as a traditional Holter monitor, cardiac event monitor and a mobile cardiac telemetry monitor. The multi functional device can be programmed remotely by the physician to accommodate the preferred form of monitoring that best suits the individual patient.
In addition to the MoMe cardiac monitoring device, InfoBionic added that the wireless device is combined with their back end cloud based analysis software in which it can receive and analyze the ECG data in real time. The cloud based back end allows physician access for analysis of the reports and electronic charting.
InfoBionic announced that the MoMe cardiac monitoring system will soon be available in the US market place.